PETALING JAYA: Duopharma Biotech Bhd, which wrapped up financial year 2022 (FY22) on a strong note with record high revenue and net profit, expects operational costs to increase in 2023.

市场参与者们，过去的周末一定不好过……今日其他重点财经新闻：国油去年净利翻倍【行家论股】今日分享的3个股项：1.MyEG（MyEG）2.联合药业（DPHARMA)3.TRC协作（TRC)...

分析：兴业投行研究目标价：1.80令吉最新进展：消费者对保健补品的需求已经正常化，但这并没有阻碍公私领域药物采购活动，让联合药业（DPHARMA，7148，主板保健股）的盈利增长继续保有韧性。联合药业也无需面对疫苗减值拨备风险；该集团去年已经为手头上总值约3000万令吉的国药疫苗（Sinopharm...

The healthcare and pharmaceutical sectors are expected to sustain their growth momentum through the reopening of international borders, higher procurement activities and better export sales, says RHB Research.

（吉隆坡7日讯）兴业投资银行将柔佛医药保健（KPJ Healthcare Bhd）列为医疗保健领域的首选股，因为患者增长强劲、护士短缺的影响较低，以及2023年首季成功脱售蒙亏的印尼子公司。该研究机构今日在报告中指出，对柔佛医药保健的前景仍持乐观态度，并认为该集团更专注于国内市场，可提供更好的盈利能...

KUALA LUMPUR (March 7): RHB Investment Bank Bhd named KPJ Healthcare Bhd as its top pick in the healthcare sector due to its robust patient growth trajectory, lower impact from nurse shortages, and successful disposal of its loss-making Indonesian unit in ...

KUALA LUMPUR (Feb 23): Here is a brief recap of some corporate announcements that made news on Thursday (Feb 23) involving Petronas Chemicals Group Bhd, Axiata Group Bhd, Maxis Bhd, Sime Darby Bhd, Genting Bhd, Genting Malaysia Bhd, Hap Seng Consolidated Bhd, ...

KUALA LUMPUR (Feb 23): Duopharma Biotech Bhd has posted a record net profit of RM70.11 million for the financial year ended Dec 31, 2022 (FY2022), eclipsing its previous milestone of RM65.68 million achieved last year.Earnings per share rose to 1.8 sen from 1.67 sen ...

（吉隆坡23日讯）联合药业（DPHARMA，7148，主板保健股）2022财政年末季录得1716万令吉净利，按年上升9....

马股于周四间低开后一度走高，闭市时又再跌破支撑水平后收低。富时隆综指于2月16日闭市时1484.26点报收， 按日再涨4.22点或0.28%。它的整日交投波幅介于11.00（1483.54至1494.54）点间。30只综指成分股项于2月16日间陷入一段技术盘整走势。上升股为527只，而下跌股为403...

（吉隆坡30日讯）尽管原料药（API）价格走高带来赚幅风险，但分析员认为，在有多项利好，包括药物供不应求、令吉逐渐回升以及本地流感病例上升，保健业短期前景仍受看好，维持对其“增持”评级。大马研究在最新的报告指出，由于中国过去3年严格管控个人购买相关药物，让药房与制药商降低库存与产量，加上去年12月底...

HARGA jualan ubat dijangka meningkat berikutan peningkatan harga bahan farmaseutikal aktif (API) iaitu bahan mentah yang digunakan untuk menghasilkan ubat-ubatan, kata penganalisis. Harga API pada peringkat global meningkat mendadak pada hujung Disember 2022, sekali gus mendorong syarikat farmaseutikal untuk melepaskan kos ...

A contract that was renewed by the government and accepted by Duopharma Biotech Bhd is expected to contribute to about a quarter of the company’s revenue in the financial year 2023.

分析员认为，联合药业（DPHARMA,7148,主板医疗保健组）供应政府药物的合约获得延长是在预料之中，关键是马币兑美元汇率若再回升，就会相应提升其2023年盈利。...

分析：大马研究目标价：1.89令吉最新进展：联合药业（DPHARMA，7148，主板保健股）子公司Duopharma（马）私人有限公司，获得Pharmaniaga物流私人有限公司颁发，延长6个月供应合约的通知。根据文告，Duopharma（马）向政府医院、诊所及相关机构，供应药品与非药物产品的合约，...

KUALA LUMPUR: Stocks that could see buying interest on Thursday include Jiankun, AIM, PLS Plantations, Duopharma Biotech, T7 Global, Uzma and Yinson, said Apex Research.

Duopharma Biotech Bhd’s wholly-owned subsidiary Duopharma (M) Sdn Bhd has received a letter from Pharmaniaga Logistics Sdn Bhd for the continued supply of pharmaceutical and/or non-pharmaceutical products to government-run hospitals and clinics until June 30, 2023.

KUALA LUMPUR (Jan 25): Here is a brief recap of some corporate announcements that made the news on Wednesday (Jan 25) involving Jiankun International Bhd, Advance Information Marketing Bhd (AIM), PLS Plantations Bhd, Duopharma Biotech Bhd, T7 Global Bhd, Uzma Bhd, Yinson ...

联合药业（DPHARMA,7148,主板医疗保健组）子公司获发马（PHARMA,7081,主板医疗保健组）通知，其政府药物或非药物产品供应合约获得延长6个月。...

KUALA LUMPUR (Jan 25): Duopharma Biotech Bhd has received another contract extension for the supply of pharmaceutical and non-pharmaceutical products to hospitals and clinics.The group said it received a letter from Pharmaniaga Logistics Sdn Bhd (PLSB), a unit of Pharmaniaga ...